{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:44:26Z","timestamp":1791863066367,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Fund of Hubei Science and Technology Department, General Project","award":["2022CFCO02"],"award-info":[{"award-number":["2022CFCO02"]}]},{"name":"Natural Science Fund of Hubei Science and Technology Department, General Project","award":["2022CFCO02"],"award-info":[{"award-number":["2022CFCO02"]}]},{"name":"Natural Science Fund of Hubei Science and Technology Department, General Project","award":["2022CFCO02"],"award-info":[{"award-number":["2022CFCO02"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01668-8","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T13:33:56Z","timestamp":1739626436000},"page":"2589-2606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["MICAL1 Mediates TGF-\u03b21-Induced Epithelial-to-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma by Activating Smad2\/3"],"prefix":"10.1007","volume":"83","author":[{"given":"Xun","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghui","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"20","key":"1668_CR1","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.3748\/wjg.v28.i20.2176","volume":"28","author":"K Lv","year":"2022","unstructured":"Lv, K., Cao, X., Du, P., Fu, J. Y., Geng, D. Y., & Zhang, J. (2022). Radiomics for the detection of microvascular invasion in hepatocellular carcinoma. World Journal of Gastroenterology, 28(20), 2176\u20132183.","journal-title":"World Journal of Gastroenterology"},{"issue":"3","key":"1668_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 71(3), 209\u2013249.","journal-title":"CA Cancer Journal for Clinicians"},{"issue":"21","key":"1668_CR3","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.12998\/wjcc.v9.i21.5754","volume":"9","author":"HY Long","year":"2021","unstructured":"Long, H. Y., Huang, T. Y., Xie, X. Y., Long, J. T., & Liu, B. X. (2021). Treatment strategies for hepatocellular carcinoma with extrahepatic metastasis. World Journal of Clinical Cases, 9(21), 5754\u20135768.","journal-title":"World Journal of Clinical Cases"},{"key":"1668_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2147\/JHC.S452924","volume":"11","author":"YQ Du","year":"2024","unstructured":"Du, Y. Q., Yuan, B., Ye, Y. X., Zhou, F. L., Liu, H., Huang, J. J., & Wei, Y. F. (2024). Plumbagin regulates snail to inhibit hepatocellular carcinoma epithelial-mesenchymal transition in vivo and in vitro. Journal of Hepatocellular Carcinoma, 11, 565\u2013580.","journal-title":"Journal of Hepatocellular Carcinoma"},{"key":"1668_CR5","doi-asserted-by":"publisher","first-page":"765101","DOI":"10.3389\/fimmu.2021.765101","volume":"12","author":"Z Liu","year":"2021","unstructured":"Liu, Z., Liu, X., Liang, J., Liu, Y., Hou, X., Zhang, M., Li, Y., & Jiang, X. (2021). Immunotherapy for hepatocellular carcinoma: Current status and future prospects. Frontiers in Immunology, 12, 765101.","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"1668_CR6","first-page":"2993","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen, Z., Xie, H., Hu, M., Huang, T., Hu, Y., Sang, N., & Zhao, Y. (2020). Recent progress in treatment of hepatocellular carcinoma. American Journal of Cancer Research, 10(9), 2993\u20133036.","journal-title":"American Journal of Cancer Research"},{"issue":"3","key":"1668_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W., & Kang, Y. (2019). Epithelial-mesenchymal plasticity in cancer progression and metastasis. Developmental Cell, 49(3), 361\u2013374.","journal-title":"Developmental Cell"},{"issue":"5","key":"1668_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1078-0432.CCR-13-3173","volume":"21","author":"HY Jung","year":"2015","unstructured":"Jung, H. Y., Fattet, L., & Yang, J. (2015). Molecular pathways: Linking tumor microenvironment to epithelial-mesenchymal transition in metastasis. Clinical Cancer Research, 21(5), 962\u2013968.","journal-title":"Clinical Cancer Research"},{"issue":"11","key":"1668_CR9","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao, Y., Baker, D., & Ten Dijke, P. (2019). TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. International Journal of Molecular Sciences, 20(11), 2767.","journal-title":"International Journal of Molecular Sciences"},{"issue":"Pt 2","key":"1668_CR10","first-page":"136","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee, J. H., & Massagu\u00e9, J. (2022). TGF-\u03b2 in developmental and fibrogenic EMTs. Seminars in Cancer Biology, 86(Pt 2), 136\u2013145.","journal-title":"Seminars in Cancer Biology"},{"key":"1668_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ceb.2014.09.001","volume":"31","author":"R Derynck","year":"2014","unstructured":"Derynck, R., Muthusamy, B. P., & Saeteurn, K. Y. (2014). Signaling pathway cooperation in TGF-\u03b2-induced epithelial-mesenchymal transition. Current Opinion in Cell Biology, 31, 56\u201366.","journal-title":"Current Opinion in Cell Biology"},{"issue":"13","key":"1668_CR12","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.3390\/cancers13133248","volume":"13","author":"E Gonzalez-Sanchez","year":"2021","unstructured":"Gonzalez-Sanchez, E., Vaquero, J., F\u00e9rnandez-Barrena, M. G., Lasarte, J. J., Avila, M. A., Sarobe, P., Reig, M., Calvo, M., & Fabregat, I. (2021). The TGF-\u03b2 pathway: A pharmacological target in hepatocellular carcinoma? Cancers, 13(13), 3248.","journal-title":"Cancers"},{"issue":"17","key":"1668_CR13","doi-asserted-by":"publisher","first-page":"14933","DOI":"10.1074\/jbc.M111842200","volume":"277","author":"T Suzuki","year":"2002","unstructured":"Suzuki, T., Nakamoto, T., Ogawa, S., Seo, S., Matsumura, T., Tachibana, K., Morimoto, C., & Hirai, H. (2002). MICAL, a novel CasL-interacting molecule, associates with vimentin. Journal of Biological Chemistry, 277(17), 14933\u201314941.","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"1668_CR14","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/genes13050715","volume":"13","author":"S Haikazian","year":"2022","unstructured":"Haikazian, S., & Olson, M. F. (2022). MICAL1 monooxygenase in autosomal dominant lateral temporal epilepsy: Role in cytoskeletal regulation and relation to cancer. Genes, 13(5), 715.","journal-title":"Genes"},{"issue":"5","key":"1668_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.2337\/db14-0719","volume":"64","author":"PK Aggarwal","year":"2015","unstructured":"Aggarwal, P. K., Veron, D., Thomas, D. B., Siegel, D., Moeckel, G., Kashgarian, M., & Tufro, A. (2015). Semaphorin3a promotes advanced diabetic nephropathy. Diabetes, 64(5), 1743\u20131759.","journal-title":"Diabetes"},{"issue":"6","key":"1668_CR16","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1111\/jcmm.13588","volume":"22","author":"W Deng","year":"2018","unstructured":"Deng, W., Wang, Y., Zhao, S., Zhang, Y., Chen, Y., Zhao, X., Liu, L., Sun, S., Zhang, L., Ye, B., & Du, J. (2018). MICAL1 facilitates breast cancer cell proliferation via ROS-sensitive ERK\/cyclin D pathway. Journal of Cellular and Molecular Medicine, 22(6), 3108\u20133118.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"1668_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03749-1","volume":"20","author":"K Cai","year":"2022","unstructured":"Cai, K., Deng, L., Zheng, D., Li, L., He, Z., & Yu, C. (2022). MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT\/\u03b2-catenin pathway. Journal of Translational Medicine, 20(1), 528.","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"1668_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10462-1","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang, Y., Ye, F., Xia, T., Wang, Q., & Du, J. (2022). High MICAL1 expression correlates with cancer progression and immune infiltration in renal clear cell carcinoma. BMC Cancer, 22(1), 1355.","journal-title":"BMC Cancer"},{"key":"1668_CR19","doi-asserted-by":"publisher","first-page":"114870","DOI":"10.1016\/j.bcp.2021.114870","volume":"195","author":"H Gu","year":"2022","unstructured":"Gu, H., Li, Y., Cui, X., Cao, H., Hou, Z., Ti, Y., Liu, D., Gao, J., Wang, Y., & Wen, P. (2022). MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1\/\u03b2-catenin signaling pathway. Biochemical Pharmacology, 195, 114870.","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"1668_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19336918.2024.2335682","volume":"18","author":"C Li","year":"2024","unstructured":"Li, C., Xiao, Y., Kong, J., Lai, C., Chen, Z., Li, Z., & Xie, W. (2024). Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches. Cell Adhesion & Migration, 18(1), 1\u201317.","journal-title":"Cell Adhesion & Migration"},{"issue":"1A","key":"1668_CR21","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak, K., Czerwi\u0144ska, P., & Wiznerowicz, M. (2015). The cancer genome atlas (TCGA): An immeasurable source of knowledge. Contemporary Oncology, 19(1A), A68\u2013A77.","journal-title":"Contemporary Oncology"},{"issue":"Database issue","key":"1668_CR22","doi-asserted-by":"publisher","first-page":"D202","DOI":"10.1093\/nar\/gkq1056","volume":"39","author":"JH Yang","year":"2011","unstructured":"Yang, J. H., Li, J. H., Shao, P., Zhou, H., Chen, Y. Q., & Qu, L. H. (2011). starBase: A database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Research, 39(Database issue), D202\u2013D209.","journal-title":"Nucleic Acids Research"},{"issue":"W1","key":"1668_CR23","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: A web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Research, 45(W1), W98\u2013w102.","journal-title":"Nucleic Acids Research"},{"issue":"11","key":"1668_CR24","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3390\/ijms22115543","volume":"22","author":"J Soukupova","year":"2021","unstructured":"Soukupova, J., Malfettone, A., Bertran, E., Hern\u00e1ndez-Alvarez, M. I., Pe\u00f1uelas-Haro, I., Dituri, F., Giannelli, G., Zorzano, A., & Fabregat, I. (2021). Epithelial-mesenchymal transition (EMT) induced by TGF-\u03b2 in hepatocellular carcinoma cells reprograms lipid metabolism. International Journal of Molecular Sciences, 22(11), 5543.","journal-title":"International Journal of Molecular Sciences"},{"key":"1668_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/978-0-387-70956-7_4","volume":"600","author":"SM Kolk","year":"2007","unstructured":"Kolk, S. M., & Pasterkamp, R. J. (2007). MICAL flavoprotein monooxygenases: Structure, function and role in semaphorin signaling. Advances in Experimental Medicine and Biology, 600, 38\u201351.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"1","key":"1668_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09614-0","volume":"22","author":"Y Yang","year":"2022","unstructured":"Yang, Y., Ye, F., Xia, T., Wang, Q., Zhang, Y., & Du, J. (2022). High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma. BMC Cancer, 22(1), 487.","journal-title":"BMC Cancer"},{"key":"1668_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.canlet.2020.04.019","volume":"483","author":"W Zhou","year":"2020","unstructured":"Zhou, W., Liu, Y., Gao, Y., Cheng, Y., Chang, R., Li, X., Zhou, Y., Wang, S., Liang, L., Duan, C., & Zhang, C. (2020). MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma. Cancer Letters, 483, 75\u201386.","journal-title":"Cancer Letters"},{"issue":"3","key":"1668_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.7150\/jca.22355","volume":"9","author":"Y Cai","year":"2018","unstructured":"Cai, Y., Lu, J., & Tang, F. (2018). Overexpression of MICAL2, a novel tumor-promoting factor, accelerates tumor progression through regulating cell proliferation and EMT. Journal of Cancer, 9(3), 521\u2013527.","journal-title":"Journal of Cancer"},{"issue":"Pt 3","key":"1668_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1242\/jcs.089367","volume":"125","author":"SS Giridharan","year":"2012","unstructured":"Giridharan, S. S., Rohn, J. L., Naslavsky, N., & Caplan, S. (2012). Differential regulation of actin microfilaments by human MICAL proteins. Journal of Cell Science, 125(Pt 3), 614\u2013624.","journal-title":"Journal of Cell Science"},{"key":"1668_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2021.07.039","volume":"519","author":"DJ McGarry","year":"2021","unstructured":"McGarry, D. J., Armstrong, G., Castino, G., Mason, S., Clark, W., Shaw, R., McGarry, L., Blyth, K., & Olson, M. F. (2021). MICAL1 regulates actin cytoskeleton organization, directional cell migration and the growth of human breast cancer cells as orthotopic xenograft tumours. Cancer Letters, 519, 226\u2013236.","journal-title":"Cancer Letters"},{"key":"1668_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fphar.2019.00291","volume":"10","author":"S Zhao","year":"2019","unstructured":"Zhao, S., Min, P., Liu, L., Zhang, L., Zhang, Y., Wang, Y., Zhao, X., Ma, Y., Xie, H., Zhu, C., Jiang, H., Du, J., & Gu, L. (2019). NEDD9 facilitates hypoxia-induced gastric cancer cell migration via MICAL1 related Rac1 activation. Frontiers in Pharmacology, 10, 291.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"1668_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/abbs\/gmx124","volume":"50","author":"R Kashima","year":"2018","unstructured":"Kashima, R., & Hata, A. (2018). The role of TGF-\u03b2 superfamily signaling in neurological disorders. Acta Biochimica et Biophysica Sinica, 50(1), 106\u2013120.","journal-title":"Acta Biochimica et Biophysica Sinica"},{"issue":"1","key":"1668_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022). Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy. Molecular Cancer, 21(1), 104.","journal-title":"Molecular Cancer"},{"issue":"1","key":"1668_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"BG Kim","year":"2021","unstructured":"Kim, B. G., Malek, E., Choi, S. H., Ignatz-Hoover, J. J., & Driscoll, J. J. (2021). Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. Journal of Hematology & Oncology, 14(1), 55.","journal-title":"Journal of Hematology & Oncology"},{"issue":"2","key":"1668_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2217\/14796694.5.2.259","volume":"5","author":"M Tian","year":"2009","unstructured":"Tian, M., & Schiemann, W. P. (2009). The TGF-beta paradox in human cancer: An update. Future Oncology, 5(2), 259\u2013271.","journal-title":"Future Oncology"},{"key":"1668_CR36","doi-asserted-by":"crossref","unstructured":"Runa, F., Ortiz-Soto G., de Barros N. R., Kelber J. A. (2024) Targeting SMAD-dependent signaling: Considerations in epithelial and mesenchymal solid tumors. Pharmaceuticals, 17(3), 326.","DOI":"10.3390\/ph17030326"},{"issue":"10","key":"1668_CR37","doi-asserted-by":"publisher","first-page":"e112806","DOI":"10.15252\/embj.2022112806","volume":"42","author":"C Fan","year":"2023","unstructured":"Fan, C., Wang, Q., Kuipers, T. B., Cats, D., Iyengar, P. V., Hagenaars, S. C., Mesker, W. E., Devilee, P., Tollenaar, R., Mei, H., & Ten Dijke, P. (2023). LncRNA LITATS1 suppresses TGF-\u03b2-induced EMT and cancer cell plasticity by potentiating T\u03b2RI degradation. The EMBO Journal, 42(10), e112806.","journal-title":"The EMBO Journal"},{"issue":"2","key":"1668_CR38","doi-asserted-by":"publisher","first-page":"e110553","DOI":"10.15252\/embj.2021110553","volume":"42","author":"J Zhang","year":"2023","unstructured":"Zhang, J., van der Zon, G., Ma, J., Mei, H., Cabukusta, B., Agaser, C. C., Maduni\u0107, K., Wuhrer, M., Zhang, T., & Ten Dijke, P. (2023). ST3GAL5-catalyzed gangliosides inhibit TGF-\u03b2-induced epithelial-mesenchymal transition via T\u03b2RI degradation. The EMBO Journal, 42(2), e110553.","journal-title":"The EMBO Journal"},{"issue":"2","key":"1668_CR39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00018-022-04672-w","volume":"80","author":"J Zhang","year":"2023","unstructured":"Zhang, J., van Dinther, M., Thorikay, M., Gourabi, B. M., Kruithof, B., & Ten Dijke, P. (2023). Opposing USP19 splice variants in TGF-\u03b2 signaling and TGF-\u03b2-induced epithelial-mesenchymal transition of breast cancer cells. Cellular and Molecular Life Sciences, 80(2), 43.","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"1668_CR40","doi-asserted-by":"publisher","first-page":"BSR20211754","DOI":"10.1042\/BSR20211754","volume":"42","author":"P Debnath","year":"2022","unstructured":"Debnath, P., Huirem, R. S., Dutta, P., & Palchaudhuri, S. (2022). Epithelial-mesenchymal transition and its transcription factors. Bioscience Reports, 42(1), BSR20211754.","journal-title":"Bioscience Reports"},{"issue":"8","key":"1668_CR41","doi-asserted-by":"publisher","first-page":"314","DOI":"10.2183\/pjab.85.314","volume":"85","author":"K Miyazono","year":"2009","unstructured":"Miyazono, K. (2009). Transforming growth factor-beta signaling in epithelial-mesenchymal transition and progression of cancer. Proceedings of the Japan Academy, Series B, Physical and Biological Sciences, 85(8), 314\u2013323.","journal-title":"Proceedings of the Japan Academy, Series B, Physical and Biological Sciences"},{"issue":"47","key":"1668_CR42","doi-asserted-by":"publisher","first-page":"78029","DOI":"10.18632\/oncotarget.12871","volume":"7","author":"M Rumman","year":"2016","unstructured":"Rumman, M., Jung, K. H., Fang, Z., Yan, H. H., Son, M. K., Kim, S. J., Kim, J., Park, J. H., Lim, J. H., Hong, S., & Hong, S. S. (2016). HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer. Oncotarget, 7(47), 78029\u201378047.","journal-title":"Oncotarget"},{"issue":"8","key":"1668_CR43","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1097\/CAD.0000000000001066","volume":"32","author":"X Chen","year":"2021","unstructured":"Chen, X., & Yan, N. (2021). Stachydrine inhibits TGF-\u03b21-induced epithelial-mesenchymal transition in hepatocellular carcinoma cells through the TGF-\u03b2\/Smad and PI3K\/Akt\/mTOR signaling pathways. Anticancer Drugs, 32(8), 786\u2013792.","journal-title":"Anticancer Drugs"},{"issue":"2","key":"1668_CR44","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2016.05.007","volume":"378","author":"G Yang","year":"2016","unstructured":"Yang, G., Liang, Y., Zheng, T., Song, R., Wang, J., Shi, H., Sun, B., Xie, C., Li, Y., Han, J., Pan, S., Lan, Y., Liu, X., Zhu, M., Wang, Y., & Liu, L. (2016). FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-\u03b2\/Smad signaling. Cancer Letters, 378(2), 80\u201386.","journal-title":"Cancer Letters"},{"issue":"12","key":"1668_CR45","doi-asserted-by":"publisher","first-page":"165537","DOI":"10.1016\/j.bbadis.2019.165537","volume":"1865","author":"Q Liu","year":"2019","unstructured":"Liu, Q., Borcherding, N., Shao, P., Cao, H., Zhang, W., & Qi, H. H. (2019). Identification of novel TGF-\u03b2 regulated genes with pro-migratory roles. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1865(12), 165537.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01668-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01668-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T08:03:48Z","timestamp":1747641828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01668-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1668"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01668-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"3 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The animal experiments were approved and supervised by the Animal Ethics Committee of the People\u2019s Hospital of Dan Yang (Approval date: 9 May 2023; Approval number: DWLL20230509023). A written informed consent was signed by each patient, and clinical tissues were collected and used under the approval of the Ethics Committee of the People\u2019s Hospital of Dan Yang (Approval date: 16 Nov 2022; Approval number: KY20221116018).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}